Clinical Trial: Multimodal Ultrasound Artificial Intelligence Model for Assessing the Feasibility of Exempting Sentinel Lymph Node Biopsy in Early Breast Cancer (China)

China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multimodal Ultrasound Artificial Intelligence Model for Assessing the Feasibility of Exempting Sentinel Lymph Node Biopsy in Early Breast Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129675

Registration Time: 2026/08/07

Type: Diagnostic test

Primary Sponsor: Northern Jiangsu People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335358

Published by HT Digital Content Services with permission from Health Daily Digest....